OpenSAFELY
Reports

Vaccine Coverage - Second Doses

Description
Monthly* report on COVID-19 vaccination coverage in England focussing on second doses which are due (i.e. where first dose was recorded at least 14 weeks ago). * updates may occasionally be subject to delay.
Contact
Get in touch and tell us how you use this report or new features you'd like to see: team@opensafely.org
First published
02 Jul 2021
Last released
26 May 2022
DOI
http://doi.org/10.53764/rpt.cd7cf36769
Links

OpenSAFELY COVID Vaccine coverage report: Second doses

OpenSAFELY is a new secure analytics platform for electronic patient records built on behalf of NHS England to deliver urgent academic and operational research during the pandemic.

This is an extension of our regular weekly report on COVID-19 vaccination coverage in England using data from 40% of general practices that use TPP electronic health record software. The data requires careful interpretation and there are a number of caveats. Please read the full detail about our methods and discussion of our earlier results (as of 17 March 2021) in our peer-reviewed publication in the British Journal of General Practice.

The full analytical methods behind the latest results in this report are available here.

Update: Our vaccine reports are currently published monthly. If you rely on more regular data updates for your own reporting or analysis please contact team@opensafely.org to let us know.

Second doses

Please note This report is intended to highlight any differences between subgroups of priority cohorts in receiving second doses, only including those which are due (i.e. where at least 14 weeks has passed since the first dose). It is therefore NOT a comprehensive view of all second doses given to date - to see these figures please refer to the main report.

Report last updated 25 May 2022

Second dose vaccinations included up to 11 May 2022 inclusive

Only persons who had their first dose between the start of the campaign (7 Dec 2020) and 14 weeks ago (02 Feb 2022) are included in the 'due' group.

Group definitions

  • As of 29 Nov 2021, patient age is calculated at 31 Aug 2021 (previously 31 March 2021), in line with national reporting.
  • The care home group is defined based on patients (aged 65+) having one of these codes.
  • The shielding group is defined based on patients (aged 16-69) having one of these codes provided it was not superceded by one of these codes.
  • The LD (learning disability) group is defined based on patients (aged 16-64) having one of these codes and excludes people who are shielding.
  • Patients are counted in their highest risk category only; e.g. a 65-year-old who is shielding is only counted in the shielding group, not in the 65-69 group.
  • The housebound group is defined based on this codelist and excludes people who were later recorded as not housebound or in a care home.

Cumulative second dose vaccination figures among 80+ population

Please refer to footnotes below table for information.

Second Doses due at 11 May 2022 (n) Second doses overdue (n) Second doses given (n) Second doses given (% of due) Total population
Category Group
overall overall 1,014,384 5,418 1,008,966 99.5 1,048,236
Sex F 586,635 3,514 583,121 99.4 606,739
M 427,749 1,911 425,838 99.6 441,497
Age band 80-84 550,655 2,709 547,946 99.5 567,784
85-89 317,443 1,778 315,665 99.4 327,635
90+ 146,286 938 145,348 99.4 152,817
Ethnicity (broad categories) Black 8,435 245 8,190 97.1 10,507
Mixed 2,716 49 2,667 98.2 3,178
Other 5,614 105 5,509 98.1 6,566
South Asian 24,724 532 24,192 97.8 27,342
Unknown 35,420 273 35,147 99.2 41,860
White 937,468 4,207 933,261 99.6 958,790
Ethnicity (detailed categories) African 1,484 70 1,414 95.3 1,988
Bangladeshi or British Bangladeshi 1,106 42 1,064 96.2 1,246
Caribbean 5,831 147 5,684 97.5 7,091
Chinese 1,414 21 1,393 98.5 1,694
Other 4,200 77 4,123 98.2 4,872
Other Asian 3,780 63 3,717 98.3 4,340
British or Mixed British 889,945 3,787 886,158 99.6 908,068
Indian or British Indian 13,440 203 13,237 98.5 14,427
Irish 8,771 70 8,701 99.2 9,156
Other Black 1,113 35 1,078 96.9 1,421
Other White 38,773 350 38,423 99.1 41,580
Other mixed 1,029 21 1,008 98.0 1,155
Pakistani or British Pakistani 6,398 231 6,167 96.4 7,329
Unknown 35,406 280 35,126 99.2 41,839
White + Asian 476 7 469 98.5 525
White + Black African 280 7 273 97.5 378
White + Black Caribbean 938 21 917 97.8 1,120
Index of Multiple Deprivation (quintiles) 1 Most deprived 124,131 1,043 123,088 99.2 131,439
2 166,327 1,071 165,256 99.4 173,355
3 229,054 1,155 227,899 99.5 236,166
4 237,580 1,085 236,495 99.5 243,992
5 Least deprived 238,154 882 237,272 99.6 243,264
Unknown 19,138 189 18,949 99.0 20,013
BMI 30+ 178,997 819 178,178 99.5 182,588
under 30 835,387 4,599 830,788 99.4 865,648
Housebound no 910,679 4,473 906,206 99.5 941,157
yes 103,705 952 102,753 99.1 107,079
Chronic cardiac disease no 703,353 3,899 699,454 99.4 730,576
yes 311,031 1,519 309,512 99.5 317,660
Current COPD no 907,816 4,900 902,916 99.5 939,428
yes 106,568 525 106,043 99.5 108,808
DMARDs no 982,030 5,292 976,738 99.5 1,015,364
yes 32,354 126 32,228 99.6 32,872
Dementia no 934,339 4,662 929,677 99.5 965,734
yes 80,045 763 79,282 99.0 82,502
Psychosis, schizophrenia, or bipolar no 1,007,202 5,341 1,001,861 99.5 1,040,620
yes 7,182 84 7,098 98.8 7,616
Learning disability no 1,013,957 5,404 1,008,553 99.5 1,047,795
yes 420 7 413 98.3 441
SSRI (last 12 months) no 974,197 5,194 969,003 99.5 1,007,419
yes 40,187 224 39,963 99.4 40,817
Chemo or radiotherapy no 978,600 5,292 973,308 99.5 1,011,857
yes 35,784 126 35,658 99.6 36,379
Cancer (lung) no 1,007,300 5,390 1,001,910 99.5 1,041,026
yes 7,077 28 7,049 99.6 7,210
Cancer (excluding lung/haem) no 824,460 4,655 819,805 99.4 854,833
yes 189,924 763 189,161 99.6 193,403
Cancer (haematological) no 995,008 5,334 989,674 99.5 1,028,524
yes 19,376 84 19,292 99.6 19,712
Chronic kidney disease no 694,988 3,899 691,089 99.4 721,938
yes 319,389 1,519 317,870 99.5 326,298
brand of first dose Moderna 518 301 217 41.9 1,624
Oxford-AZ 266,238 1,918 264,320 99.3 266,245
Pfizer 746,858 3,185 743,673 99.6 747,859
Unknown 770 21 749 97.3 770

Footnotes:

  • Patient counts rounded to the nearest 7.
  • Only persons who are currently registered and had their first dose at least 14 weeks ago are included in the 'due' group.
  • Population excludes those known to live in an elderly care home, based upon clinical coding.
  • SSRIs group excludes individuals with Psychosis/ schizophrenia/bipolar, LD, or Dementia.
  • Chronic kidney disease is defined as the presence of a relevant diagnostic code, or a most recent stage recorded >= 3.

Second Doses Overdue Among 80+ Population

Second doses which have not been given at least 14 weeks since the first dose

Error bars indicate possible error caused by rounding

Cumulative second dose vaccination figures among 70-79 population

Please refer to footnotes below table for information.

Second Doses due at 11 May 2022 (n) Second doses overdue (n) Second doses given (n) Second doses given (% of due) Total population
Category Group
overall overall 2,010,351 13,993 1,996,358 99.3 2,088,891
Sex F 1,057,896 7,637 1,050,259 99.3 1,098,363
M 952,441 6,356 946,085 99.3 990,521
Age band 70-74 1,148,231 9,401 1,138,830 99.2 1,197,931
75-79 862,106 4,592 857,514 99.5 890,953
Ethnicity (broad categories) Black 11,599 420 11,179 96.4 14,938
Mixed 5,740 126 5,614 97.8 6,699
Other 13,713 364 13,349 97.3 16,338
South Asian 51,800 1,323 50,477 97.4 57,267
Unknown 90,958 868 90,090 99.0 104,104
White 1,836,527 10,892 1,825,635 99.4 1,889,531
Ethnicity (detailed categories) African 4,011 203 3,808 94.9 5,390
Bangladeshi or British Bangladeshi 1,708 77 1,631 95.5 1,939
Caribbean 5,362 147 5,215 97.3 6,755
Chinese 3,640 84 3,556 97.7 4,431
Other 10,073 287 9,786 97.2 11,893
Other Asian 10,423 259 10,164 97.5 11,774
British or Mixed British 1,744,575 9,807 1,734,768 99.4 1,787,765
Indian or British Indian 29,141 595 28,546 98.0 31,444
Irish 14,679 140 14,539 99.0 15,498
Other Black 2,226 70 2,156 96.9 2,793
Other White 77,252 938 76,314 98.8 86,247
Other mixed 2,359 42 2,317 98.2 2,688
Pakistani or British Pakistani 10,521 385 10,136 96.3 12,110
Unknown 90,972 861 90,111 99.1 104,125
White + Asian 1,281 28 1,253 97.8 1,428
White + Black African 889 28 861 96.9 1,099
White + Black Caribbean 1,225 28 1,197 97.7 1,491
Index of Multiple Deprivation (quintiles) 1 Most deprived 253,050 2,366 250,684 99.1 269,402
2 335,083 2,688 332,395 99.2 351,379
3 451,528 3,045 448,483 99.3 468,279
4 468,090 2,877 465,213 99.4 483,203
5 Least deprived 462,252 2,429 459,823 99.5 474,005
Unknown 40,348 602 39,746 98.5 42,595
BMI 30+ 503,636 2,996 500,640 99.4 515,879
under 30 1,506,701 10,990 1,495,711 99.3 1,572,998
Housebound no 1,971,088 13,489 1,957,599 99.3 2,048,095
yes 39,249 504 38,745 98.7 40,782
Chronic cardiac disease no 1,636,012 11,662 1,624,350 99.3 1,704,752
yes 374,332 2,338 371,994 99.4 384,125
Current COPD no 1,817,634 12,810 1,804,824 99.3 1,891,295
yes 192,703 1,176 191,527 99.4 197,582
DMARDs no 1,937,222 13,678 1,923,544 99.3 2,014,404
yes 73,115 315 72,800 99.6 74,473
Dementia no 1,966,538 13,538 1,953,000 99.3 2,043,811
yes 43,799 455 43,344 99.0 45,073
Psychosis, schizophrenia, or bipolar no 1,991,563 13,699 1,977,864 99.3 2,068,731
yes 18,774 294 18,480 98.4 20,146
Learning disability no 2,007,614 13,958 1,993,656 99.3 2,086,028
yes 2,730 42 2,688 98.5 2,849
SSRI (last 12 months) no 1,907,206 13,321 1,893,885 99.3 1,983,884
yes 103,131 672 102,459 99.3 105,000
Chemo or radiotherapy no 1,938,818 13,671 1,925,147 99.3 2,016,007
yes 71,526 329 71,197 99.5 72,870
Cancer (lung) no 1,996,904 13,909 1,982,995 99.3 2,075,164
yes 13,440 91 13,349 99.3 13,713
Cancer (excluding lung/haem) no 1,713,845 12,502 1,701,343 99.3 1,786,134
yes 296,492 1,491 295,001 99.5 302,743
Cancer (haematological) no 1,978,963 13,832 1,965,131 99.3 2,056,852
yes 31,381 168 31,213 99.5 32,025
Chronic kidney disease no 1,742,461 12,523 1,729,938 99.3 1,815,016
yes 267,883 1,477 266,406 99.4 273,861
brand of first dose Moderna 2,002 1,239 763 38.1 3,171
Oxford-AZ 1,203,552 4,557 1,198,995 99.6 1,203,566
Pfizer 802,767 8,155 794,612 99.0 804,125
Unknown 2,016 42 1,974 97.9 2,065

Footnotes:

  • Patient counts rounded to the nearest 7.
  • Only persons who are currently registered and had their first dose at least 14 weeks ago are included in the 'due' group.
  • Population excludes those known to live in an elderly care home, based upon clinical coding.
  • SSRIs group excludes individuals with Psychosis/ schizophrenia/bipolar, LD, or Dementia.
  • Chronic kidney disease is defined as the presence of a relevant diagnostic code, or a most recent stage recorded >= 3.

Second Doses Overdue Among 70-79 Population

Second doses which have not been given at least 14 weeks since the first dose

Error bars indicate possible error caused by rounding

Cumulative second dose vaccination figures among care home population

Please refer to footnotes below table for information.

Second Doses due at 11 May 2022 (n) Second doses overdue (n) Second doses given (n) Second doses given (% of due) Total population
Category Group
overall overall 107,359 1,890 105,469 98.2 112,301
Sex F 75,145 1,253 73,892 98.3 78,379
M 32,207 637 31,570 98.0 33,915
Age band 65-69 6,132 154 5,978 97.5 6,545
70-74 9,772 196 9,576 98.0 10,360
75-79 14,014 266 13,748 98.1 14,735
80-84 19,845 371 19,474 98.1 20,748
85-89 25,711 427 25,284 98.3 26,845
90+ 31,878 469 31,409 98.5 33,068
Ethnicity (broad categories) Black 651 35 616 94.6 763
Mixed 336 7 329 97.9 364
Other 511 7 504 98.6 539
South Asian 987 42 945 95.7 1,057
Unknown 1,890 35 1,855 98.1 2,044
White 102,977 1,764 101,213 98.3 107,527
Dementia no 49,147 896 48,251 98.2 52,066
yes 58,205 987 57,218 98.3 60,235
brand of first dose Moderna 133 56 77 57.9 707
Oxford-AZ 71,288 441 70,847 99.4 71,288
Pfizer 35,728 1,393 34,335 96.1 36,400
Unknown 203 7 196 96.6 203

Footnotes:

  • Patient counts rounded to the nearest 7.
  • Only persons who are currently registered and had their first dose at least 14 weeks ago are included in the 'due' group.
  • Population includes those known to live in an elderly care home, based upon clinical coding.

Second Doses Overdue Among Care Home Population

Second doses which have not been given at least 14 weeks since the first dose

Error bars indicate possible error caused by rounding

Cumulative second dose vaccination figures among shielding (aged 16-69) population

Please refer to footnotes below table for information.

Second Doses due at 11 May 2022 (n) Second doses overdue (n) Second doses given (n) Second doses given (% of due) Total population
Category Group
overall overall 753,970 17,486 736,484 97.7 819,252
newly shielded since feb 15 no 451,066 8,211 442,855 98.2 481,334
yes 302,897 9,268 293,629 96.9 337,918
Sex F 425,628 10,507 415,121 97.5 462,910
M 328,328 6,986 321,342 97.9 356,321
Age band 16-29 56,735 2,996 53,739 94.7 66,815
30-39 109,669 4,361 105,308 96.0 125,832
40-49 150,234 3,955 146,279 97.4 164,878
50-59 213,087 3,654 209,433 98.3 227,500
60-69 224,224 2,513 221,711 98.9 234,206
Ethnicity (broad categories) Black 35,532 1,645 33,887 95.4 44,513
Mixed 11,767 490 11,277 95.8 14,273
Other 15,253 539 14,714 96.5 17,969
South Asian 98,301 3,129 95,172 96.8 107,590
Unknown 19,348 371 18,977 98.1 21,819
White 573,755 11,312 562,443 98.0 613,067
Index of Multiple Deprivation (quintiles) 1 Most deprived 211,498 6,685 204,813 96.8 237,804
2 168,063 4,102 163,961 97.6 183,813
3 145,565 2,842 142,723 98.0 156,429
4 116,214 1,967 114,247 98.3 122,948
5 Least deprived 91,805 1,239 90,566 98.7 95,662
Unknown 20,804 651 20,153 96.9 22,575
Learning disability no 728,560 16,926 711,634 97.7 792,295
yes 25,396 567 24,829 97.8 26,936
Chronic kidney disease no 699,412 16,674 682,738 97.6 761,614
yes 54,544 812 53,732 98.5 57,624
brand of first dose Moderna 3,129 1,183 1,946 62.2 3,430
Oxford-AZ 468,209 7,329 460,880 98.4 468,209
Pfizer 281,946 8,932 273,014 96.8 283,192
Unknown 665 42 623 93.7 679

Footnotes:

  • Patient counts rounded to the nearest 7.
  • Only persons who are currently registered and had their first dose at least 14 weeks ago are included in the 'due' group.
  • Population excludes those over 65 known to live in an elderly care home, based upon clinical coding.
  • Chronic kidney disease is defined as the presence of a relevant diagnostic code, or a most recent stage recorded >= 3.

Second Doses Overdue Among Shielding (Aged 16-69) Population

Second doses which have not been given at least 14 weeks since the first dose

Error bars indicate possible error caused by rounding

Cumulative second dose vaccination figures among 65-69 population

Please refer to footnotes below table for information.

Second Doses due at 11 May 2022 (n) Second doses overdue (n) Second doses given (n) Second doses given (% of due) Total population
Category Group
overall overall 1,026,648 12,369 1,014,279 98.8 1,093,519
Sex F 528,731 6,454 522,277 98.8 560,721
M 497,910 5,915 491,995 98.8 532,791
Ethnicity (broad categories) Black 8,974 357 8,617 96.0 11,802
Mixed 4,354 119 4,235 97.3 5,250
Other 10,430 350 10,080 96.6 13,034
South Asian 41,293 1,309 39,984 96.8 46,165
Unknown 62,223 868 61,355 98.6 74,655
White 899,374 9,366 890,008 99.0 942,606
Ethnicity (detailed categories) African 3,521 175 3,346 95.0 4,669
Bangladeshi or British Bangladeshi 1,743 56 1,687 96.8 1,932
Caribbean 3,493 112 3,381 96.8 4,676
Chinese 3,381 126 3,255 96.3 4,235
Other 7,035 224 6,811 96.8 8,785
Other Asian 7,700 245 7,455 96.8 8,778
British or Mixed British 849,331 8,267 841,064 99.0 881,559
Indian or British Indian 22,050 623 21,427 97.2 24,108
Irish 6,405 119 6,286 98.1 6,937
Other Black 1,960 70 1,890 96.4 2,464
Other White 43,645 980 42,665 97.8 54,131
Other mixed 1,715 49 1,666 97.1 2,051
Pakistani or British Pakistani 9,807 399 9,408 95.9 11,340
Unknown 62,223 868 61,355 98.6 74,648
White + Asian 973 28 945 97.1 1,078
White + Black African 728 21 707 97.1 945
White + Black Caribbean 945 28 917 97.0 1,169
Index of Multiple Deprivation (quintiles) 1 Most deprived 139,433 2,170 137,263 98.4 154,637
2 177,289 2,366 174,923 98.7 191,674
3 228,851 2,688 226,163 98.8 243,019
4 232,540 2,457 230,083 98.9 244,524
5 Least deprived 225,659 2,093 223,566 99.1 234,948
Unknown 22,869 588 22,281 97.4 24,710
BMI 30+ 265,643 2,730 262,913 99.0 275,870
under 30 761,005 9,646 751,359 98.7 817,635
Housebound no 1,021,804 12,271 1,009,533 98.8 1,088,304
yes 4,837 98 4,739 98.0 5,208
Chronic cardiac disease no 913,150 11,109 902,041 98.8 975,044
yes 113,498 1,267 112,231 98.9 118,461
Current COPD no 985,565 11,872 973,693 98.8 1,050,378
yes 41,083 497 40,586 98.8 43,127
DMARDs no 1,006,075 12,194 993,881 98.8 1,072,281
yes 20,573 182 20,391 99.1 21,231
Dementia no 1,020,649 12,285 1,008,364 98.8 1,087,212
yes 5,999 84 5,915 98.6 6,300
Psychosis, schizophrenia, or bipolar no 1,016,022 12,131 1,003,891 98.8 1,081,696
yes 10,619 231 10,388 97.8 11,816
Learning disability no 1,024,310 12,334 1,011,976 98.8 1,091,020
yes 2,331 35 2,296 98.5 2,492
SSRI (last 12 months) no 966,126 11,690 954,436 98.8 1,031,121
yes 60,515 679 59,836 98.9 62,384
Chemo or radiotherapy no 1,005,935 12,187 993,748 98.8 1,072,120
yes 20,706 182 20,524 99.1 21,392
Cancer (lung) no 1,024,359 12,348 1,012,011 98.8 1,091,111
yes 2,289 28 2,261 98.8 2,394
Cancer (excluding lung/haem) no 934,444 11,550 922,894 98.8 998,074
yes 92,204 826 91,378 99.1 95,431
Cancer (haematological) no 1,022,574 12,327 1,010,247 98.8 1,089,256
yes 4,074 49 4,025 98.8 4,256
Chronic kidney disease no 975,191 11,823 963,368 98.8 1,040,158
yes 51,457 553 50,904 98.9 53,354
brand of first dose Moderna 2,226 1,582 644 28.9 2,401
Oxford-AZ 677,110 3,619 673,491 99.5 677,110
Pfizer 346,059 7,119 338,940 97.9 346,577
Unknown 1,246 49 1,197 96.1 1,281

Footnotes:

  • Patient counts rounded to the nearest 7.
  • Only persons who are currently registered and had their first dose at least 14 weeks ago are included in the 'due' group.
  • Population excludes those known to live in an elderly care home, based upon clinical coding.
  • Population excludes those who are shielding.
  • SSRIs group excludes individuals with Psychosis/ schizophrenia/bipolar, LD, or Dementia.
  • Chronic kidney disease is defined as the presence of a relevant diagnostic code, or a most recent stage recorded >= 3.

Second Doses Overdue Among 65-69 Population

Second doses which have not been given at least 14 weeks since the first dose

Error bars indicate possible error caused by rounding

Cumulative second dose vaccination figures among Learning Disabilities (aged 16-64) population

Please refer to footnotes below table for information.

Second Doses due at 11 May 2022 (n) Second doses overdue (n) Second doses given (n) Second doses given (% of due) Total population
Category Group
overall overall 76,314 2,898 73,416 96.2 86,394
Sex F 29,386 987 28,399 96.6 32,648
M 46,928 1,911 45,017 95.9 53,739
Age band 16-17 3,906 434 3,472 88.9 5,110
18-29 26,656 1,253 25,403 95.3 31,311
30-34 9,814 364 9,450 96.3 11,221
35-39 7,315 238 7,077 96.7 8,134
40-44 5,817 182 5,635 96.9 6,321
45-49 5,691 133 5,558 97.7 6,111
50-54 6,195 112 6,083 98.2 6,601
55-59 6,167 105 6,062 98.3 6,573
60-64 4,746 77 4,669 98.4 4,998
Ethnicity (broad categories) Black 994 84 910 91.5 1,484
Mixed 910 56 854 93.8 1,211
Other 630 28 602 95.6 805
South Asian 4,193 273 3,920 93.5 5,082
Unknown 4,543 140 4,403 96.9 5,236
White 65,037 2,317 62,720 96.4 72,569
brand of first dose Moderna 602 189 413 68.6 658
Oxford-AZ 49,791 973 48,818 98.0 49,791
Pfizer 25,872 1,743 24,129 93.3 26,152
Unknown 49 0 49 100.0 49

Footnotes:

  • Patient counts rounded to the nearest 7.
  • Only persons who are currently registered and had their first dose at least 14 weeks ago are included in the 'due' group.
  • Population excludes those who are shielding.

Second Doses Overdue Among People With Learning Disabilities (Aged 16-64)

Second doses which have not been given at least 14 weeks since the first dose

Error bars indicate possible error caused by rounding

Cumulative second dose vaccination figures among 60-64 population

Please refer to footnotes below table for information.

Second Doses due at 11 May 2022 (n) Second doses overdue (n) Second doses given (n) Second doses given (% of due) Total population
Category Group
overall overall 1,213,758 17,528 1,196,230 98.6 1,314,376
Sex F 612,276 8,855 603,421 98.6 656,495
M 601,475 8,673 592,802 98.6 657,867
Ethnicity (broad categories) Black 15,484 616 14,868 96.0 20,972
Mixed 6,958 224 6,734 96.8 8,533
Other 14,077 490 13,587 96.5 18,018
South Asian 49,056 1,449 47,607 97.0 55,342
Unknown 86,317 1,246 85,071 98.6 105,546
White 1,041,852 13,510 1,028,342 98.7 1,105,944
Ethnicity (detailed categories) African 6,153 259 5,894 95.8 8,071
Bangladeshi or British Bangladeshi 2,212 91 2,121 95.9 2,457
Caribbean 5,705 231 5,474 96.0 8,148
Chinese 4,431 175 4,256 96.1 5,502
Other 9,653 315 9,338 96.7 12,523
Other Asian 10,465 315 10,150 97.0 12,033
British or Mixed British 977,795 11,907 965,888 98.8 1,024,016
Indian or British Indian 25,081 651 24,430 97.4 27,762
Irish 6,349 119 6,230 98.1 7,028
Other Black 3,633 126 3,507 96.5 4,753
Other White 57,624 1,477 56,147 97.4 74,823
Other mixed 2,653 84 2,569 96.8 3,283
Pakistani or British Pakistani 11,291 392 10,899 96.5 13,083
Unknown 86,373 1,246 85,127 98.6 105,602
White + Asian 1,421 28 1,393 98.0 1,596
White + Black African 1,281 49 1,232 96.2 1,589
White + Black Caribbean 1,624 63 1,561 96.1 2,093
Index of Multiple Deprivation (quintiles) 1 Most deprived 176,512 3,465 173,047 98.0 201,579
2 214,991 3,444 211,547 98.4 237,055
3 266,868 3,640 263,228 98.6 287,546
4 269,822 3,381 266,441 98.7 287,245
5 Least deprived 257,887 2,744 255,143 98.9 270,690
Unknown 27,664 854 26,810 96.9 30,247
BMI 30+ 308,791 3,920 304,871 98.7 323,400
under 30 904,960 13,608 891,352 98.5 990,962
Chronic cardiac disease no 1,117,305 16,254 1,101,051 98.5 1,212,505
yes 96,446 1,281 95,165 98.7 101,864
Current COPD no 1,178,191 16,905 1,161,286 98.6 1,276,548
yes 35,553 616 34,937 98.3 37,814
DMARDs no 1,192,184 17,311 1,174,873 98.5 1,291,871
yes 21,567 217 21,350 99.0 22,491
Dementia no 1,209,852 17,465 1,192,387 98.6 1,310,239
yes 3,899 63 3,836 98.4 4,123
Psychosis, schizophrenia, or bipolar no 1,200,227 17,157 1,183,070 98.6 1,299,004
yes 13,524 378 13,146 97.2 15,358
SSRI (last 12 months) no 1,130,997 16,338 1,114,659 98.6 1,228,185
yes 82,754 1,197 81,557 98.6 86,184
Chemo or radiotherapy no 1,194,816 17,339 1,177,477 98.5 1,294,699
yes 18,935 189 18,746 99.0 19,663
Cancer (lung) no 1,212,218 17,500 1,194,718 98.6 1,312,724
yes 1,526 21 1,505 98.6 1,638
Cancer (excluding lung/haem) no 1,137,143 16,695 1,120,448 98.5 1,234,380
yes 76,608 840 75,768 98.9 79,982
Cancer (haematological) no 1,210,097 17,486 1,192,611 98.6 1,310,505
yes 3,647 35 3,612 99.0 3,864
Chronic kidney disease no 1,180,872 17,115 1,163,757 98.6 1,279,866
yes 32,879 413 32,466 98.7 34,503
brand of first dose Moderna 3,892 2,625 1,267 32.6 4,151
Oxford-AZ 887,768 5,999 881,769 99.3 887,782
Pfizer 320,656 8,827 311,829 97.2 321,447
Unknown 1,428 77 1,351 94.6 1,456

Footnotes:

  • Patient counts rounded to the nearest 7.
  • Only persons who are currently registered and had their first dose at least 14 weeks ago are included in the 'due' group.
  • Population excludes those who are shielding.
  • SSRIs group excludes individuals with Psychosis/ schizophrenia/bipolar, LD, or Dementia.
  • Chronic kidney disease is defined as the presence of a relevant diagnostic code, or a most recent stage recorded >= 3.

Second Doses Overdue Among 60-64 Population

Second doses which have not been given at least 14 weeks since the first dose

Error bars indicate possible error caused by rounding

Cumulative second dose vaccination figures among 55-59 population

Please refer to footnotes below table for information.

Second Doses due at 11 May 2022 (n) Second doses overdue (n) Second doses given (n) Second doses given (% of due) Total population
Category Group
overall overall 1,400,637 23,716 1,376,921 98.3 1,547,371
Sex F 702,597 11,431 691,166 98.4 762,069
M 698,033 12,285 685,748 98.2 785,288
Ethnicity (broad categories) Black 24,304 1,106 23,198 95.4 33,334
Mixed 10,472 343 10,129 96.7 13,139
Other 18,760 686 18,074 96.3 24,542
South Asian 55,769 1,631 54,138 97.1 63,630
Unknown 104,881 1,799 103,082 98.3 133,056
White 1,186,444 18,144 1,168,300 98.5 1,279,649
Ethnicity (detailed categories) African 10,486 462 10,024 95.6 13,825
Bangladeshi or British Bangladeshi 2,870 84 2,786 97.1 3,199
Caribbean 7,532 385 7,147 94.9 11,144
Chinese 5,698 231 5,467 95.9 7,126
Other 13,062 462 12,600 96.5 17,416
Other Asian 13,727 420 13,307 96.9 16,016
British or Mixed British 1,106,973 16,002 1,090,971 98.6 1,174,481
Indian or British Indian 26,754 686 26,068 97.4 29,834
Irish 7,357 175 7,182 97.6 8,365
Other Black 6,279 245 6,034 96.1 8,372
Other White 72,100 1,967 70,133 97.3 96,789
Other mixed 3,731 112 3,619 97.0 4,711
Pakistani or British Pakistani 12,411 441 11,970 96.4 14,574
Unknown 104,916 1,806 103,110 98.3 133,091
White + Asian 2,142 63 2,079 97.1 2,457
White + Black African 1,981 84 1,897 95.8 2,506
White + Black Caribbean 2,618 98 2,520 96.3 3,451
Index of Multiple Deprivation (quintiles) 1 Most deprived 212,478 5,222 207,256 97.5 249,634
2 249,732 4,900 244,832 98.0 282,198
3 304,346 4,998 299,348 98.4 334,369
4 307,104 4,298 302,806 98.6 332,052
5 Least deprived 295,463 3,409 292,054 98.8 314,146
Unknown 31,507 889 30,618 97.2 34,958
BMI 30+ 343,329 4,977 338,352 98.6 363,475
under 30 1,057,301 18,739 1,038,562 98.2 1,183,882
Chronic cardiac disease no 1,327,354 22,442 1,304,912 98.3 1,468,796
yes 73,276 1,274 72,002 98.3 78,554
Current COPD no 1,372,728 23,051 1,349,677 98.3 1,517,033
yes 27,902 658 27,244 97.6 30,324
DMARDs no 1,378,909 23,471 1,355,438 98.3 1,524,481
yes 21,721 245 21,476 98.9 22,876
Psychosis, schizophrenia, or bipolar no 1,383,809 23,121 1,360,688 98.3 1,527,834
yes 16,821 595 16,226 96.5 19,523
SSRI (last 12 months) no 1,295,931 21,987 1,273,944 98.3 1,437,443
yes 104,699 1,722 102,977 98.4 109,914
Chronic kidney disease no 1,378,643 23,415 1,355,228 98.3 1,523,928
yes 21,987 301 21,686 98.6 23,429
brand of first dose Moderna 5,509 3,206 2,303 41.8 5,852
Oxford-AZ 1,081,507 9,149 1,072,358 99.2 1,081,514
Pfizer 312,151 11,249 300,902 96.4 313,313
Unknown 1,463 105 1,358 92.8 1,498

Footnotes:

  • Patient counts rounded to the nearest 7.
  • Only persons who are currently registered and had their first dose at least 14 weeks ago are included in the 'due' group.
  • Population excludes those who are shielding.
  • SSRIs group excludes individuals with Psychosis/ schizophrenia/bipolar, LD, or Dementia.
  • Chronic kidney disease is defined as the presence of a relevant diagnostic code, or a most recent stage recorded >= 3.

Second Doses Overdue Among 55-59 Population

Second doses which have not been given at least 14 weeks since the first dose

Error bars indicate possible error caused by rounding

Cumulative second dose vaccination figures among 50-54 population

Please refer to footnotes below table for information.

Second Doses due at 11 May 2022 (n) Second doses overdue (n) Second doses given (n) Second doses given (% of due) Total population
Category Group
overall overall 1,405,698 28,987 1,376,711 97.9 1,591,961
Sex F 706,629 13,293 693,336 98.1 777,707
M 699,055 15,687 683,368 97.8 814,247
Ethnicity (broad categories) Black 28,161 1,435 26,726 94.9 39,137
Mixed 12,467 490 11,977 96.1 16,086
Other 23,919 994 22,925 95.8 31,997
South Asian 78,561 2,534 76,027 96.8 91,182
Unknown 112,511 2,247 110,264 98.0 146,783
White 1,150,072 21,287 1,128,785 98.1 1,266,762
Ethnicity (detailed categories) African 15,484 763 14,721 95.1 20,566
Bangladeshi or British Bangladeshi 4,774 126 4,648 97.4 5,320
Caribbean 5,936 329 5,607 94.5 9,317
Chinese 6,622 280 6,342 95.8 8,372
Other 17,297 714 16,583 95.9 23,625
Other Asian 19,152 616 18,536 96.8 22,708
British or Mixed British 1,056,104 18,214 1,037,890 98.3 1,135,540
Indian or British Indian 33,180 889 32,291 97.3 37,625
Irish 7,154 203 6,951 97.2 8,365
Other Black 6,734 343 6,391 94.9 9,247
Other White 86,800 2,870 83,930 96.7 122,850
Other mixed 4,522 182 4,340 96.0 5,978
Pakistani or British Pakistani 21,462 896 20,566 95.8 25,543
Unknown 112,532 2,240 110,292 98.0 146,804
White + Asian 2,688 70 2,618 97.4 3,150
White + Black African 2,646 126 2,520 95.2 3,444
White + Black Caribbean 2,590 105 2,485 95.9 3,500
Index of Multiple Deprivation (quintiles) 1 Most deprived 226,296 7,329 218,967 96.8 276,556
2 255,829 6,265 249,564 97.6 298,011
3 298,291 5,747 292,544 98.1 335,601
4 301,133 4,949 296,184 98.4 331,282
5 Least deprived 291,452 3,738 287,714 98.7 313,537
Unknown 32,683 952 31,731 97.1 36,960
BMI 30+ 331,653 5,677 325,976 98.3 355,362
under 30 1,074,031 23,303 1,050,728 97.8 1,236,585
Chronic cardiac disease no 1,358,042 27,888 1,330,154 97.9 1,539,748
yes 47,642 1,092 46,550 97.7 52,206
Current COPD no 1,387,358 28,441 1,358,917 97.9 1,571,591
yes 18,326 539 17,787 97.1 20,356
DMARDs no 1,386,819 28,721 1,358,098 97.9 1,571,843
yes 18,865 259 18,606 98.6 20,104
Psychosis, schizophrenia, or bipolar no 1,388,688 28,259 1,360,429 98.0 1,571,535
yes 16,996 721 16,275 95.8 20,412
SSRI (last 12 months) no 1,294,461 26,852 1,267,609 97.9 1,474,249
yes 111,223 2,128 109,095 98.1 117,698
Chronic kidney disease no 1,393,553 28,742 1,364,811 97.9 1,578,815
yes 12,131 238 11,893 98.0 13,132
brand of first dose Moderna 9,926 3,416 6,510 65.6 10,395
Oxford-AZ 1,104,817 11,963 1,092,854 98.9 1,104,831
Pfizer 289,373 13,468 275,905 95.3 290,976
Unknown 1,568 133 1,435 91.5 1,603

Footnotes:

  • Patient counts rounded to the nearest 7.
  • Only persons who are currently registered and had their first dose at least 14 weeks ago are included in the 'due' group.
  • Population excludes those who are shielding.
  • SSRIs group excludes individuals with Psychosis/ schizophrenia/bipolar, LD, or Dementia.
  • Chronic kidney disease is defined as the presence of a relevant diagnostic code, or a most recent stage recorded >= 3.

Second Doses Overdue Among 50-54 Population

Second doses which have not been given at least 14 weeks since the first dose

Error bars indicate possible error caused by rounding

Cumulative second dose vaccination figures among 40-49 population

Please refer to footnotes below table for information.

Second Doses due at 11 May 2022 (n) Second doses overdue (n) Second doses given (n) Second doses given (% of due) Total population
Category Group
overall overall 2,444,876 77,924 2,366,952 96.8 3,009,384
Sex F 1,236,837 34,468 1,202,369 97.2 1,439,480
M 1,208,004 43,456 1,164,548 96.4 1,569,855
Ethnicity (broad categories) Black 64,449 3,990 60,459 93.8 95,382
Mixed 31,234 1,589 29,645 94.9 44,009
Other 65,772 3,339 62,433 94.9 96,411
South Asian 221,571 9,478 212,093 95.7 278,663
Unknown 183,379 5,957 177,422 96.8 271,285
White 1,878,429 53,564 1,824,865 97.1 2,223,578
Ethnicity (detailed categories) African 42,833 2,548 40,285 94.1 60,291
Bangladeshi or British Bangladeshi 16,352 623 15,729 96.2 19,446
Caribbean 7,903 574 7,329 92.7 14,763
Chinese 17,612 903 16,709 94.9 24,521
Other 48,139 2,429 45,710 95.0 71,862
Other Asian 51,912 2,219 49,693 95.7 66,570
British or Mixed British 1,639,918 43,785 1,596,133 97.3 1,839,236
Indian or British Indian 91,994 3,150 88,844 96.6 115,269
Irish 11,718 455 11,263 96.1 15,169
Other Black 13,699 868 12,831 93.7 20,314
Other White 226,779 9,324 217,455 95.9 369,159
Other mixed 12,117 616 11,501 94.9 17,598
Pakistani or British Pakistani 61,313 3,486 57,827 94.3 77,371
Unknown 183,414 5,964 177,450 96.7 271,327
White + Asian 6,818 245 6,573 96.4 8,680
White + Black African 7,357 406 6,951 94.5 10,178
White + Black Caribbean 4,949 315 4,634 93.6 7,567
Index of Multiple Deprivation (quintiles) 1 Most deprived 423,591 21,987 401,604 94.8 581,357
2 455,616 17,080 438,536 96.3 587,440
3 504,455 14,672 489,783 97.1 617,673
4 500,010 11,991 488,019 97.6 587,706
5 Least deprived 489,188 9,387 479,801 98.1 550,312
Unknown 71,974 2,800 69,174 96.1 84,840
BMI 30+ 472,353 12,656 459,697 97.3 526,953
under 30 1,972,481 65,261 1,907,220 96.7 2,482,375
Chronic cardiac disease no 2,406,747 76,601 2,330,146 96.8 2,965,634
yes 38,094 1,316 36,778 96.5 43,694
Current COPD no 2,430,561 77,231 2,353,330 96.8 2,992,486
yes 14,280 693 13,587 95.1 16,842
DMARDs no 2,419,718 77,427 2,342,291 96.8 2,981,615
yes 25,123 497 24,626 98.0 27,713
Psychosis, schizophrenia, or bipolar no 2,414,321 76,153 2,338,168 96.8 2,971,045
yes 30,513 1,764 28,749 94.2 38,283
SSRI (last 12 months) no 2,271,997 72,569 2,199,428 96.8 2,819,831
yes 172,844 5,348 167,496 96.9 189,504
Chronic kidney disease no 2,434,327 77,637 2,356,690 96.8 2,997,596
yes 10,507 280 10,227 97.3 11,739
brand of first dose Moderna 92,421 8,911 83,510 90.4 94,052
Oxford-AZ 1,667,400 25,466 1,641,934 98.5 1,667,435
Pfizer 681,632 43,099 638,533 93.7 687,232
Unknown 3,388 448 2,940 86.8 3,437

Footnotes:

  • Patient counts rounded to the nearest 7.
  • Only persons who are currently registered and had their first dose at least 14 weeks ago are included in the 'due' group.
  • SSRIs group excludes individuals with Psychosis/ schizophrenia/bipolar, LD, or Dementia.
  • Chronic kidney disease is defined as the presence of a relevant diagnostic code, or a most recent stage recorded >= 3.

Second Doses Overdue Among 40-49 Population

Second doses which have not been given at least 14 weeks since the first dose

Error bars indicate possible error caused by rounding

Cumulative second dose vaccination figures among 30-39 population

Please refer to footnotes below table for information.

Second Doses due at 11 May 2022 (n) Second doses overdue (n) Second doses given (n) Second doses given (% of due) Total population
Category Group
overall overall 2,462,488 136,605 2,325,883 94.5 3,415,650
Sex F 1,269,184 63,371 1,205,813 95.0 1,651,034
M 1,193,234 73,234 1,120,000 93.9 1,764,504
Ethnicity (broad categories) Black 58,450 6,279 52,171 89.3 104,160
Mixed 39,529 3,122 36,407 92.1 64,820
Other 73,724 5,642 68,082 92.3 127,743
South Asian 248,612 17,584 231,028 92.9 354,452
Unknown 186,718 10,472 176,246 94.4 300,482
White 1,855,385 93,506 1,761,879 95.0 2,463,881
Ethnicity (detailed categories) African 39,655 4,165 35,490 89.5 65,604
Bangladeshi or British Bangladeshi 17,332 1,113 16,219 93.6 23,254
Caribbean 6,776 770 6,006 88.6 16,275
Chinese 18,039 1,099 16,940 93.9 32,627
Other 55,699 4,543 51,156 91.8 95,102
Other Asian 55,370 4,200 51,170 92.4 80,962
British or Mixed British 1,586,228 76,300 1,509,928 95.2 1,929,494
Indian or British Indian 105,945 6,482 99,463 93.9 152,033
Irish 11,011 700 10,311 93.6 17,024
Other Black 12,005 1,337 10,668 88.9 22,281
Other White 258,090 16,506 241,584 93.6 517,321
Other mixed 15,925 1,176 14,749 92.6 26,397
Pakistani or British Pakistani 69,972 5,796 64,176 91.7 98,210
Unknown 186,760 10,465 176,295 94.4 300,531
White + Asian 8,778 546 8,232 93.8 12,481
White + Black African 7,224 623 6,601 91.4 11,557
White + Black Caribbean 7,595 777 6,818 89.8 14,378
Index of Multiple Deprivation (quintiles) 1 Most deprived 480,046 38,703 441,343 91.9 761,656
2 498,190 30,737 467,453 93.8 730,744
3 507,934 25,851 482,083 94.9 695,968
4 464,772 20,489 444,283 95.6 600,145
5 Least deprived 398,202 14,805 383,397 96.3 486,822
Unknown 113,267 6,013 107,254 94.7 140,196
brand of first dose Moderna 156,590 17,626 138,964 88.7 160,573
Oxford-AZ 547,827 13,132 534,695 97.6 547,841
Pfizer 1,753,367 105,091 1,648,276 94.0 1,768,697
Unknown 4,634 756 3,878 83.7 4,676

Footnotes:

  • Patient counts rounded to the nearest 7.
  • Only persons who are currently registered and had their first dose at least 14 weeks ago are included in the 'due' group.

Second Doses Overdue Among 30-39 Population

Second doses which have not been given at least 14 weeks since the first dose

Error bars indicate possible error caused by rounding

Cumulative second dose vaccination figures among 18-29 population

Please refer to footnotes below table for information.

Second Doses due at 11 May 2022 (n) Second doses overdue (n) Second doses given (n) Second doses given (% of due) Total population
Category Group
overall overall 2,497,943 215,859 2,282,084 91.4 3,553,935
Sex F 1,276,002 103,467 1,172,535 91.9 1,752,149
M 1,221,717 112,371 1,109,346 90.8 1,801,485
Ethnicity (broad categories) Black 54,502 9,163 45,339 83.2 109,620
Mixed 47,509 5,768 41,741 87.9 80,801
Other 76,531 12,362 64,169 83.8 152,999
South Asian 219,765 25,466 194,299 88.4 329,280
Unknown 332,430 23,275 309,155 93.0 488,306
White 1,766,982 139,804 1,627,178 92.1 2,392,628
Ethnicity (detailed categories) African 34,881 5,943 28,938 83.0 66,227
Bangladeshi or British Bangladeshi 17,584 1,960 15,624 88.9 24,871
Caribbean 6,804 1,043 5,761 84.7 16,905
Chinese 28,875 6,041 22,834 79.1 61,999
Other 47,621 6,307 41,314 86.8 90,958
Other Asian 48,902 6,020 42,882 87.7 75,705
British or Mixed British 1,584,758 120,253 1,464,505 92.4 1,998,710
Indian or British Indian 88,403 9,149 79,254 89.7 126,826
Irish 8,372 952 7,420 88.6 13,517
Other Black 12,817 2,170 10,647 83.1 26,474
Other White 173,768 18,606 155,162 89.3 380,338
Other mixed 17,437 2,079 15,358 88.1 30,282
Pakistani or British Pakistani 64,869 8,330 56,539 87.2 101,871
Unknown 332,514 23,282 309,232 93.0 488,397
White + Asian 12,250 1,281 10,969 89.5 17,710
White + Black African 7,623 1,078 6,545 85.9 13,384
White + Black Caribbean 10,227 1,330 8,897 87.0 19,460
Index of Multiple Deprivation (quintiles) 1 Most deprived 484,596 57,365 427,231 88.2 805,308
2 512,218 49,112 463,106 90.4 764,533
3 520,100 42,224 477,876 91.9 720,384
4 470,806 34,146 436,660 92.7 618,156
5 Least deprived 411,544 24,549 386,995 94.0 513,534
Unknown 98,455 8,449 90,006 91.4 131,719
brand of first dose Moderna 191,870 29,743 162,127 84.5 200,403
Oxford-AZ 345,695 10,073 335,622 97.1 345,716
Pfizer 1,954,169 175,280 1,778,889 91.0 1,986,544
Unknown 5,985 735 5,250 87.7 6,055

Footnotes:

  • Patient counts rounded to the nearest 7.
  • Only persons who are currently registered and had their first dose at least 14 weeks ago are included in the 'due' group.

Second Doses Overdue Among 18-29 Population

Second doses which have not been given at least 14 weeks since the first dose

Error bars indicate possible error caused by rounding

Cumulative second dose vaccination figures among 16-17 population

Please refer to footnotes below table for information.

Second Doses due at 11 May 2022 (n) Second doses overdue (n) Second doses given (n) Second doses given (% of due) Total population
Category Group
overall overall 369,670 67,424 302,246 81.8 539,826
Sex F 187,187 32,690 154,497 82.5 264,117
M 182,448 34,720 147,728 81.0 275,667
Ethnicity (broad categories) Black 6,783 2,352 4,431 65.3 17,787
Mixed 7,791 1,792 5,999 77.0 14,630
Other 7,406 1,680 5,726 77.3 15,057
South Asian 27,531 6,769 20,762 75.4 46,011
Unknown 68,859 11,319 57,540 83.6 98,637
White 251,272 43,505 207,767 82.7 347,669
Index of Multiple Deprivation (quintiles) 1 Most deprived 64,484 18,109 46,375 71.9 122,052
2 64,421 14,098 50,323 78.1 101,885
3 73,934 13,076 60,858 82.3 103,852
4 76,825 11,060 65,765 85.6 100,303
5 Least deprived 81,571 9,506 72,065 88.3 99,505
Unknown 8,400 1,568 6,832 81.3 12,180
brand of first dose Moderna 1,218 609 609 50.0 1,792
Oxford-AZ 2,002 77 1,925 96.2 2,002
Pfizer 366,282 66,710 299,572 81.8 377,741
Unknown 133 7 126 94.7 140

Footnotes:

  • Patient counts rounded to the nearest 7.
  • Only persons who are currently registered and had their first dose at least 14 weeks ago are included in the 'due' group.

Second Doses Overdue Among 16-17 Population

Second doses which have not been given at least 14 weeks since the first dose

Error bars indicate possible error caused by rounding

Summary

Second Doses due at 11 May 2022 (n) Second doses given (% of due) Second doses given (n) Second doses overdue (n) Total population
80+ 1,014,384 99.5 1,008,966 5,418 1,048,236
70-79 2,010,351 99.3 1,996,358 13,993 2,088,891
care home 107,359 98.2 105,469 1,890 112,301
shielding (aged 16-69) 753,970 97.7 736,484 17,486 819,252
65-69 1,026,648 98.8 1,014,279 12,369 1,093,519
LD (aged 16-64) 76,314 96.2 73,416 2,898 86,394
60-64 1,213,758 98.6 1,196,230 17,528 1,314,376
55-59 1,400,637 98.3 1,376,921 23,716 1,547,371
50-54 1,405,698 97.9 1,376,711 28,987 1,591,961
40-49 2,444,876 96.8 2,366,952 77,924 3,009,384
30-39 2,462,488 94.5 2,325,883 136,605 3,415,650
18-29 2,497,943 91.4 2,282,084 215,859 3,553,935
16-17 369,670 81.8 302,246 67,424 539,826